Evan Thackaberry - 01 Mar 2023 Form 4 Insider Report for Vigil Neuroscience, Inc. (VIGL)

Role
SVP, Head of Early Development
Signature
/s/ Jennifer Ziolkowski, Attorney-in-Fact
Issuer symbol
VIGL
Transactions as of
01 Mar 2023
Net transactions value
$0
Form type
4
Filing time
03 Mar 2023, 16:08:53 UTC
Previous filing
06 May 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VIGL Stock Option Grant (Right to Buy) Award $0 +65,000 $0.000000 65,000 01 Mar 2023 Common Stock 65,000 $11.87 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to this option shall vest and become exercisable in forty-eight (48) equal monthly installments, with the first installment vesting on April 1, 2023.